The effect of insulin on BCAA plasma levels has been investigated for the first time in patients with type 1 diabetes [54, 55] and results showed that the withdrawal of insulin treatment was associated with a substantial increase in circulating BCAA concentrations, as confirmed by others [58, 59]. This evidence concerns the gene INS and type 1 diabetes mellitus.